“Cholangiocarcinomas are cancers that have poor prognosis and limited treatment options.
Marijuana and its derivatives have been used in medicine for many centuries.
…cannabinoids might be effective antitumoral agents because of their ability to inhibit the growth of various types of cancer cell lines in culture and in laboratory animals.
Indeed, we have recently demonstrated that the endocannabinoid anandamide (AEA) has antiproliferative effects on cholangiocarcinoma cell lines in vitro via a cannabinoid receptor-independent pathway involving the stabilization of lipid raft-membrane structures and the recruitment of death-receptor complexes into the lipid rafts.
Modulation of the endocannabinoid system may be important in cholangiocarcinoma treatment.
The antiproliferative actions of the noncanonical Wnt signaling pathway warrants further investigation to dissect the mechanism by which this may occur.
We propose that the development of novel therapeutic strategies aimed at modulating the endocannabinoid system, or mimicking the mode of action of AEA, would prove beneficial for the treatment of this devastating disease.”
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604798/
